Cargando…

Editorial: Novel and Improved Methods for the Prevention and Treatment of Graft-Versus-Host Disease (GVHD)

Detalles Bibliográficos
Autores principales:	Ullrich, Evelyn, Beilhack, Andreas, Wolf, Dietlinde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280825/ https://www.ncbi.nlm.nih.gov/pubmed/35844562 http://dx.doi.org/10.3389/fimmu.2022.966389

Ejemplares similares

Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation
por: Czech, Marie, et al.
Publicado: (2022)

Editorial: Interferons and GvHD
por: Kim, Boram, et al.
Publicado: (2022)

T Helper Cell Lineage-Defining Transcription Factors: Potent Targets for Specific GVHD Therapy?
por: Campe, Julia, et al.
Publicado: (2022)

Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease
por: Betts, Brian C., et al.
Publicado: (2019)

Editorial: Regulatory T cells in graft versus host disease
por: Rodríguez-Gil, Alfonso, et al.
Publicado: (2023)

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
por: Mankarious, Matthew, et al.
Publicado: (2020)

Editorial: Non-coding RNAs and Graft versus Host Disease
por: Reddy, Pavan, et al.
Publicado: (2018)

Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
por: Mhandire, Kudakwashe, et al.
Publicado: (2021)

Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective
por: Mariotti, Jacopo, et al.
Publicado: (2023)

Hydrogen therapy may be an effective and specific novel treatment for Acute Graft-versus-host disease (GVHD)
por: Qian, Liren, et al.
Publicado: (2013)

A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease
por: Bäuerlein, Carina A., et al.
Publicado: (2021)

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
por: Demosthenous, Christos, et al.
Publicado: (2021)

Serum MicroRNA-155 in Acute Graft-Versus-Host-Disease (aGVHD)
por: Efebera, Yvonne A, et al.
Publicado: (2019)

GVHD Prophylaxis 2020
por: Gooptu, Mahasweta, et al.
Publicado: (2021)

Controversies and expectations for the prevention of GVHD: A biological and clinical perspective
por: Watkins, Benjamin, et al.
Publicado: (2022)

Relation between Acute GVHD and NK Cell Subset Reconstitution Following Allogeneic Stem Cell Transplantation
por: Ullrich, Evelyn, et al.
Publicado: (2016)

Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage
por: Ara, Takahide, et al.
Publicado: (2021)

T-Cell Metabolism in Graft Versus Host Disease
por: Karl, Franziska, et al.
Publicado: (2021)

Photoconversion of Alloreactive T Cells in Murine Peyer’s Patches During Acute Graft-Versus-Host Disease: Tracking the Homing Route of Highly Proliferative Cells In Vivo
por: Jarick, Katja J., et al.
Publicado: (2018)

Economic evaluation of posaconazole versus fluconazole prophylaxis in patients with graft-versus-host disease (GVHD) in the Netherlands
por: Jansen, Jeroen P., et al.
Publicado: (2010)

Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease
por: Crossland, Rachel E., et al.
Publicado: (2020)

BET Bromodomain Inhibitors Which Permit Treg Function Enable a Combinatorial Strategy to Suppress GVHD in Pre-clinical Allogeneic HSCT
por: Copsel, Sabrina N., et al.
Publicado: (2019)

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
por: Jiang, Hua, et al.
Publicado: (2021)

Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects
por: Meinhardt, Kathrin, et al.
Publicado: (2015)

Exosomes, MDSCs and Tregs: A new frontier for GVHD prevention and treatment
por: Hess, Nicholas J., et al.
Publicado: (2023)

Targeting Glycolysis in Alloreactive T Cells to Prevent Acute Graft-Versus-Host Disease While Preserving Graft-Versus-Leukemia Effect
por: Huang, Ying, et al.
Publicado: (2022)

Regulatory T Cells in GVHD Therapy
por: Guo, Wen-wen, et al.
Publicado: (2021)

Milestones in acute GVHD pathophysiology
por: Socie, Gerard, et al.
Publicado: (2022)

Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease
por: Rayasam, Aditya, et al.
Publicado: (2021)

NOTCH and Graft-Versus-Host Disease
por: Di Ianni, Mauro, et al.
Publicado: (2018)

Alemtuzumab as graft-versus-host disease (GVHD) prophylaxis strategy in a developing country: lower rate of acute GVHD, increased risk of cytomegalovirus reactivation
por: Resende, C.B., et al.
Publicado: (2017)

Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies
por: Naserian, Sina, et al.
Publicado: (2020)

GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models
por: Hess, Nicholas J., et al.
Publicado: (2021)

Interleukin-27 Enforces Regulatory T Cell Functions to Prevent Graft-versus-Host Disease
por: Le, Hongnga T., et al.
Publicado: (2020)

Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
por: Nunes, Natalia S., et al.
Publicado: (2019)

Recent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
por: Mohamed, Fathima A., et al.
Publicado: (2021)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
por: Dekker, Linde, et al.
Publicado: (2022)

Impact of oral microbiota on pathophysiology of GVHD
por: Yamamoto, Akira, et al.
Publicado: (2023)

Novel pre-clinical mouse models for chronic Graft-versus-Host Disease
por: Verlaat, Lydia, et al.
Publicado: (2023)

Novel therapies for graft versus host disease with a focus on cell therapies
por: Zeiser, Robert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pudu31dcoh2kuda4vuokaj6038